Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Begg

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
Urology|March 1, 1997
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center resultsW R Fair, M S Cookson, N Stroumbakis, et al.
The British Journal of Dermatology|January 21, 2020
Association of IRF4 single-nucleotide polymorphism rs12203592 with melanoma-specific survivalS V Ward, D C Gibbs, I Orlow, et al.
The British Journal of Dermatology|September 15, 2019
A risk prediction model for the development of subsequent primary melanoma in a population-based cohortA E Cust, C Badcock, J Smith, et al.
The British Journal of Dermatology|July 2, 2017
Functional melanoma-risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomasD C Gibbs, S V Ward, I Orlow, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
Urology|March 1, 1997
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center resultsW R Fair, M S Cookson, N Stroumbakis, et al.
The British Journal of Dermatology|January 21, 2020
Association of IRF4 single-nucleotide polymorphism rs12203592 with melanoma-specific survivalS V Ward, D C Gibbs, I Orlow, et al.
The British Journal of Dermatology|September 15, 2019
A risk prediction model for the development of subsequent primary melanoma in a population-based cohortA E Cust, C Badcock, J Smith, et al.
The British Journal of Dermatology|July 2, 2017
Functional melanoma-risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomasD C Gibbs, S V Ward, I Orlow, et al.
Pageof 11